PL215886B1 - Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka - Google Patents

Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka

Info

Publication number
PL215886B1
PL215886B1 PL384978A PL38497808A PL215886B1 PL 215886 B1 PL215886 B1 PL 215886B1 PL 384978 A PL384978 A PL 384978A PL 38497808 A PL38497808 A PL 38497808A PL 215886 B1 PL215886 B1 PL 215886B1
Authority
PL
Poland
Prior art keywords
extract
evening primrose
seeds
solution
defatted
Prior art date
Application number
PL384978A
Other languages
English (en)
Polish (pl)
Other versions
PL384978A1 (pl
Inventor
Marek Naruszewicz
Anna Kiss
Original Assignee
Agropharm Spolka Akcyjna
Anna Kiss
Marek Naruszewicz
Univ Warszawski Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agropharm Spolka Akcyjna, Anna Kiss, Marek Naruszewicz, Univ Warszawski Medyczny filed Critical Agropharm Spolka Akcyjna
Priority to PL384978A priority Critical patent/PL215886B1/pl
Priority to PCT/PL2009/000035 priority patent/WO2009128738A2/fr
Publication of PL384978A1 publication Critical patent/PL384978A1/pl
Publication of PL215886B1 publication Critical patent/PL215886B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL384978A 2008-04-18 2008-04-18 Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka PL215886B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL384978A PL215886B1 (pl) 2008-04-18 2008-04-18 Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka
PCT/PL2009/000035 WO2009128738A2 (fr) 2008-04-18 2009-04-17 Utilisation de l'extrait de graines déshuilées de primevère

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL384978A PL215886B1 (pl) 2008-04-18 2008-04-18 Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka

Publications (2)

Publication Number Publication Date
PL384978A1 PL384978A1 (pl) 2009-10-26
PL215886B1 true PL215886B1 (pl) 2014-02-28

Family

ID=41199606

Family Applications (1)

Application Number Title Priority Date Filing Date
PL384978A PL215886B1 (pl) 2008-04-18 2008-04-18 Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka

Country Status (2)

Country Link
PL (1) PL215886B1 (fr)
WO (1) WO2009128738A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2829277A1 (fr) 2013-07-26 2015-01-28 Natac Biotech, S.L. Utilisation de proanthocyanidines de type a pour traiter une maladie liée au récepteur minéralocorticoïde
GB201413228D0 (en) 2014-07-25 2014-09-10 Nugerontix Ltd Polyphenol compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018416A1 (fr) * 1998-09-30 2000-04-06 Industrial Research Limited Compositions d'antioxydants et leur procede de preparation
CN1168462C (zh) * 2001-08-17 2004-09-29 中国科学院植物研究所 一种可降血脂、改善心肌缺血及心肌梗塞症状的口服液

Also Published As

Publication number Publication date
WO2009128738A2 (fr) 2009-10-22
WO2009128738A3 (fr) 2010-06-10
PL384978A1 (pl) 2009-10-26

Similar Documents

Publication Publication Date Title
Akila et al. Chlorogenic acid ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes
Choi et al. Antioxidative and anti-inflammatory effect of quercetin and its glycosides isolated from mampat (Cratoxylum formosum)
Honma et al. Anti-hyperglycemic effects of sugar maple Acer saccharum and its constituent acertannin
EP2444093A1 (fr) Formulation d'un mélange de flavonoïdes et de flavanes à cycle B libre et de flavanes en tant qu'agent thérapeutique
Kessy et al. Enrichment and biotransformation of phenolic compounds from litchi pericarps with angiotensin I-converting enzyme (ACE) inhibition activity
Siegień et al. Pancreatic lipase and α-amylase inhibitory activity of extracts from selected plant materials after gastrointestinal digestion in vitro
Li et al. Proanthocyanidins, isolated from Choerospondias axillaris fruit peels, exhibit potent antioxidant activities in vitro and a novel anti-angiogenic property in vitro and in vivo
KR101793153B1 (ko) 검정콩잎 추출물 및 이로부터 분리한 플라보놀배당체를 유효성분으로 함유하는 대사증후군의 예방 또는 치료용, 또는 항산화용 조성물
Hyun et al. Inhibitory activities of Cassia tora and its anthraquinone constituents on angiotensin‐converting enzyme
US10028970B2 (en) Composition comprising cashew apple extract
JP2002322067A (ja) フロリジン−リッチなフェノール性画分および化粧剤、食餌療法剤またはニュートラシューティカル剤としてのその使用
Xiong et al. Phenolic content, anti-inflammatory properties, and dermal wound repair properties of industrially processed and non-processed acai from the Brazilian Amazon
AU2012266308A1 (en) Composition comprising cashew apple extract
US20020192314A1 (en) Dietary supplement compositions
Nugroho et al. Isolation and quantitative analysis of peroxynitrite scavengers from Artemisia princeps var. orientalis
US20230014918A1 (en) Compositions for use as antioxidant
Les et al. Rock tea (Jasonia glutinosa (L.) DC.) polyphenolic extract inhibits triglyceride accumulation in 3T3-L1 adipocyte-like cells and obesity related enzymes in vitro
KR20090132899A (ko) 혈행개선용 솔잎 발효액
PL215886B1 (pl) Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka
Manzanilla Valdez et al. Antidiabetic and hypotensive effect of Cnidoscolus aconitifolius (Mill) IM Johnst leaves extracts
KR20090128957A (ko) 두충 껍질 추출물을 이용한 고혈압 예방 음료 및 그제조방법
KR101881653B1 (ko) 혈행 개선 팥 껍질 추출물의 추출방법 및 이를 유효성분으로 함유하는 혈행 개선 조성물
KR100824615B1 (ko) 울금 추출물을 함유하는 동맥경화 및 고혈압의 예방 및치료용 약학조성물
KR100898509B1 (ko) 단삼 추출물을 포함하는 혈전 형성 예방용 기능성 식품 및 약학 조성물
US8445040B2 (en) Extracts of Sclerocarya birrea